Literature DB >> 24102192

Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin D and adipocytokine concentrations in pregnancies with and without gestational diabetes.

Ruth McManus1, Kelly Summers, Barbra de Vrijer, Nicole Cohen, Alexandra Thompson, Isabelle Giroux.   

Abstract

OBJECTIVE: Gestational diabetes mellitus (GDM) has been associated with inflammation as well as Vitamin D insufficiency. While Vitamin D has anti-inflammatory properties, relationships between Vitamin D and inflammatory markers remain unexplored in GDM. Therefore, this case--control study investigated adipocytokine and Vitamin D [25(OH)D] concentrations and correlations in GDM and control women, as well as their neonates. DESIGN/PARTICIPANTS/MEASUREMENTS: seventy-three women participated: 36 GDM and 37 controls. Maternal samples were drawn at 31 weeks. Umbilical arterial and venous samples were collected at birth. 25(OH)D and adipocytokine concentrations were compared for GDM vs control maternal, umbilical arterial and venous samples. Correlations were explored between biochemical results, maternal and neonatal demographics.
RESULTS: Compared with age- and weight-matched control participants, GDM women had significantly lower concentrations of 25(OH)D (77·3 ± 24·3 vs 93·2 ± 19·2 nm/l; P = 0·009); adiponectin (17·5 ± 11·8 vs 34·1 ± 20·3 μg/ml, P < 0·001); resistin (25·4 ± 9·1 vs 31·9 ± 12·1 ng/ml, P = 0·045); and plasminogen activator inhibitor-1 (PAI-1) 13·9 ± 10·0 vs 21·0 ± 12·6 ng/ml, P = 0·038), while delivering 1 week earlier (38·2 ± 1·2 vs 39·5 ± 0·9 weeks, P < 0·001). GDM maternal 25(OH)D concentrations positively correlated with PAI-1, IL-8 and TNF-α concentrations. Umbilical 25(OH)D concentrations were not significantly different in GDM vs control offspring, whereas adiponectin, resistin and PAI-1 concentrations were significantly lower in GDM offspring.
CONCLUSIONS: GDM women had lower 25(OH)D concentrations than controls, while neonatal umbilical concentrations of 25(OH)D did not differ. GDM maternal and GDM offspring had lower adiponectin, resistin and PAI-1 concentrations compared with controls. Results suggest that both GDM women and their offspring demonstrate abnormal adipocytokine patterns.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24102192     DOI: 10.1111/cen.12325

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  16 in total

Review 1.  ENDOCRINOLOGY IN PREGNANCY: Influence of maternal vitamin D status on obstetric outcomes and the fetal skeleton.

Authors:  Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Eur J Endocrinol       Date:  2015-04-10       Impact factor: 6.664

Review 2.  Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus.

Authors:  Dodie L Arnold; Daniel A Enquobahrie; Chungfang Qiu; Jonathan Huang; Nancy Grote; Ann VanderStoep; Michelle A Williams
Journal:  Paediatr Perinat Epidemiol       Date:  2015-03-23       Impact factor: 3.980

3.  Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates.

Authors:  Spyridon N Karras; Stergios A Polyzos; Danforth A Newton; Carol L Wagner; Bruce W Hollis; Jody van den Ouweland; Erdinc Dursun; Duygu Gezen-Ak; Kalliopi Kotsa; Cedric Annweiler; Declan P Naughton
Journal:  Endocrine       Date:  2017-11-18       Impact factor: 3.633

Review 4.  Maternal vitamin D supplementation during pregnancy.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Br Med Bull       Date:  2018-06-01       Impact factor: 4.291

Review 5.  Vitamin D Deficiency Increases the Risk of Gestational Diabetes Mellitus: A Meta-Analysis of Observational Studies.

Authors:  Meng-Xi Zhang; Guo-Tao Pan; Jian-Fen Guo; Bing-Yan Li; Li-Qiang Qin; Zeng-Li Zhang
Journal:  Nutrients       Date:  2015-10-01       Impact factor: 5.717

Review 6.  Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus.

Authors:  Sally K Abell; Barbora De Courten; Jacqueline A Boyle; Helena J Teede
Journal:  Int J Mol Sci       Date:  2015-06-11       Impact factor: 5.923

Review 7.  Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Authors:  Yao Ye; Aurelia Vattai; Xi Zhang; Junyan Zhu; Christian J Thaler; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

8.  Ficolin-3/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women.

Authors:  Xiao-Song Yuan; Hui Shi; Hui-Yan Wang; Bin Yu; Jian Jiang
Journal:  J Diabetes Investig       Date:  2017-05-29       Impact factor: 4.232

9.  Comparison of Serum Levels of Vitamin D and Inflammatory Markers Between Women With Gestational Diabetes Mellitus and Healthy Pregnant Control.

Authors:  Fatemeh Haidari; Mohammad-Taha Jalali; Nahid Shahbazian; Mohammad-Hossein Haghighizadeh; Elham Azadegan
Journal:  J Family Reprod Health       Date:  2016-03

Review 10.  Akt/mTOR Role in Human Foetoplacental Vascular Insulin Resistance in Diseases of Pregnancy.

Authors:  Roberto Villalobos-Labra; Luis Silva; Mario Subiabre; Joaquín Araos; Rocío Salsoso; Bárbara Fuenzalida; Tamara Sáez; Fernando Toledo; Marcelo González; Claudia Quezada; Fabián Pardo; Delia I Chiarello; Andrea Leiva; Luis Sobrevia
Journal:  J Diabetes Res       Date:  2017-09-14       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.